OXN 2503
Laufzeit: 01.01.2011 - 31.12.2013
imported
Kurzfassung
An exploratory, randomised, double-blind, placebo-controlled, parallel group, pilot study to assess the analgesic efficacy of oxycodone/naloxone prolonged release tablets (OXN PR) compared to placebo in opioid-naïve Subjects suffering from severe pain due to Bladder Pain Syndrome (BPS). Phase II